OPALEYE MANAGEMENT INC. purchased 0.5% of their position (14.63K shares) of GRACE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $29.7K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 10/13/2026ACC: 0001493152-26-046899
10% Owner
Since Aug 2026
+14.63K
Net shares
Net buyer
$29.7K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
14.63K acquired
Non-Derivative Transactions3
Common Stock, par value $0.0001 per share
Indirect
Shares
+2.08K
Price / share
$2.02
Trade value
$4.19K
% of position
0.1%
10/8/2026
2.86M→2.86M
Common Stock, par value $0.0001 per share
Indirect
Shares
+5.34K
Price / share
$2.04
Trade value
$10.92K
% of position
0.2%
10/9/2026
2.86M→2.87M
Common Stock, par value $0.0001 per share
Indirect
Shares
+7.21K
Price / share
$2.02
Trade value
$14.57K
% of position
0.3%
10/12/2026
2.87M→2.87M
Total
Net shares
+14.63K
Net value
$29.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Indirect | 10/8/2026 | P · Purchase | +2.08K | $2.02 | $4.19K | 0.1% | 2.86M | 2.86M |
| Common Stock, par value $0.0001 per share Indirect | 10/9/2026 | P · Purchase | +5.34K | $2.04 | $10.92K | 0.2% | 2.86M | 2.87M |
| Common Stock, par value $0.0001 per share Indirect | 10/12/2026 | P · Purchase | +7.21K | $2.02 | $14.57K | 0.3% | 2.87M | 2.87M |
| Total | +14.63K | $29.68K | ||||||
Derivative Transactions0
No derivative transactions reported